Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
The molecular features that define clear cell renal cell carcinoma (ccRCC) initiation and
progression are being increasingly defined. The TRACERx Renal studies and others that …
progression are being increasingly defined. The TRACERx Renal studies and others that …
Pheochromocytoma and paraganglioma
HPH Neumann, WF Young Jr… - New England journal of …, 2019 - Mass Medical Soc
Pheochromocytoma and Paraganglioma Pheochromocytoma and paraganglioma are
related tumors that differ mainly in location; pheochromocytomas are adrenal, and …
related tumors that differ mainly in location; pheochromocytomas are adrenal, and …
[HTML][HTML] Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
Currently, renal cell carcinoma (RCC) is the most prevalent type of kidney cancer. Targeted
therapy has replaced radiation therapy and chemotherapy as the main treatment option for …
therapy has replaced radiation therapy and chemotherapy as the main treatment option for …
Hypoxic control of metastasis
EB Rankin, AJ Giaccia - Science, 2016 - science.org
Metastatic disease is the leading cause of cancer-related deaths and involves critical
interactions between tumor cells and the microenvironment. Hypoxia is a potent …
interactions between tumor cells and the microenvironment. Hypoxia is a potent …
[HTML][HTML] Multiple primary tumours: challenges and approaches, a review
A Vogt, S Schmid, K Heinimann, H Frick, C Herrmann… - ESMO open, 2017 - Elsevier
When in a patient more than one tumour in the same or a different organ is diagnosed,
multiple primary tumours may be present. For epidemiological studies, different definitions of …
multiple primary tumours may be present. For epidemiological studies, different definitions of …
FDA approval summary: belzutifan for von Hippel-Lindau disease–associated tumors
Abstract On August 13, 2021, the FDA approved belzutifan (WELIREG, Merck), a first-in-
class hypoxia-inducible factor (HIF) inhibitor for adult patients with von Hippel-Lindau (VHL) …
class hypoxia-inducible factor (HIF) inhibitor for adult patients with von Hippel-Lindau (VHL) …
Regulation of erythropoiesis by hypoxia-inducible factors
VH Haase - Blood reviews, 2013 - Elsevier
A classic physiologic response to systemic hypoxia is the increase in red blood cell
production. Hypoxia-inducible factors (HIFs) orchestrate this response by inducing cell-type …
production. Hypoxia-inducible factors (HIFs) orchestrate this response by inducing cell-type …
Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms
Neuroendocrine neoplasms constitute a diverse group of tumors that derive from the
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …
[HTML][HTML] A review of Von Hippel-Lindau syndrome
N Varshney, AA Kebede… - Journal of Kidney …, 2017 - ncbi.nlm.nih.gov
Abstract Von Hippel-Lindau syndrome (VHL) is a familial neoplastic condition seen in
approximately 1 in 36,000 live births. It is caused by germline mutations of the tumor …
approximately 1 in 36,000 live births. It is caused by germline mutations of the tumor …
Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms
A Mafficini, A Scarpa - Endocrine reviews, 2019 - academic.oup.com
Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are heterogeneous
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …